Skip to content

Overview

  • Despite the solid gains in global equity indexes in 2025, we still believe conditions remain favorable for the rotational bull market to continue.
  • We expect real US gross domestic product (GDP) to grow at 2.5% with moderating inflation, ongoing Federal Reserve (Fed) interest-rate cuts, a robust fiscal impulse and a broad-based earnings recovery to drive further equity gains over our tactical horizon. With the Fed likely to ease, monetary easing may continue in many emerging markets as well. 
  • We think market leadership will continue to broaden and that two often-overlooked equity market segments are poised to outperform: US small caps and emerging markets (EMs).

This paper serves as a sequel to three research papers we published beginning in January 2025 and offers a potential road map for investors seeking opportunities in 2026. We will discuss the following:

  • Market broadening—revisiting our January 2025 theme
  • What’s ahead—potential for an earnings-driven bull market
  • Why small caps may shine
  • International opportunities are still compelling, with EMs poised to lead
     

Conclusion

With the US economy showing strong growth and the Fed resuming its interest rate-cutting cycle in 2025, the environment looks increasingly favorable for corporate earnings to expand. It may be an opportune time to consider increasing allocations to equities, as our research indicates they are poised for potential further gains.

Our research themes in 2025 emphasized the likelihood for equity market performance to broaden beyond the Magnificent Seven.1 As we have entered 2026, our analysis of the capital markets continues to favor the likelihood of broadening performance. Here, we highlight two areas of equity markets that may be especially attractive—US small caps and emerging markets. Investors often avoid these areas of the market, but we believe they should instead take a closer look.

The recent struggles of small-cap companies can be attributed primarily to their vulnerability to rising interest rates, which significantly increased borrowing costs and pressured their profitability. However, with interest rates now at lower levels and perhaps more rate cuts ahead, the outlook for small caps is becoming increasingly favorable.

As a result, this rate-sensitive asset class may experience a notable resurgence in performance. Our research finds valuations attractive on an historical basis, adding a potential tailwind to performance.

EMs are also becoming more attractive. Easing global monetary conditions should make local funding cheaper for EM companies, while also improving currency dynamics. Our research shows EM equities are currently undervalued relative to developed markets, offering what we consider significant upside potential as global financial conditions stabilize and growth prospects improve. We believe companies in EMs that are projected to deliver stronger earnings growth than their counterparts in the United States, Europe and Japan, now may be an opportune time to consider increasing exposure to this asset class.



IMPORTANT LEGAL INFORMATION

Information on this website is intended to be of general information only and does not constitute investment or financial product advice. It expresses no views as to the suitability of the products or services described as to the individual circumstances, objectives, financial situation, or needs of any investor. You should conduct your own investigation or consult a financial adviser before making any decision to invest. Please read the relevant Product Disclosure Statements (PDSs), and any associated reference documents before making an investment decision.

Neither Franklin Templeton Australia, nor any other company within the Franklin Templeton group guarantees the performance of any Fund, nor do they provide any guarantee in respect of the repayment of your capital. In accordance with the Design and Distribution Obligations, we maintain Target Market Determinations (TMD) for each of our Funds. All documents can be found via the Literature Page or by calling 1800 673 776. 

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.